Molecular surveillance of hepatitis C virus genotypes identifies the emergence of a genotype 4d lineage among men in Quebec, 2001–2017

by Murphy, DG, Dion, R, Simard, M, Vachon, ML, Martel-Laferrière, V, Serhir, B, Longtin, J
Published in Can Commun Dis Rep (2019)

Virologic Response Rates of Telaprevir-based Hepatitis C Triple Therapy in Patients with and without HIV Co-infection

by Martel-Laferrière, V, Brinkley, S, Bichoupan, K, Posner, S, Stivala, A, Perumalswami, P, Schiano, TD, Sulkowski, M, Dieterich, DT, Branch, AD
Published 2013

Clinical characteristics of HIV patients being referred for liver transplant evaluation: a descriptive cohort study

by Martel-Laferrière, V., Michel, A., Schaefer, S., Bindal, S., Bichoupan, K., Branch, A.D., Huprikar, S., Schiano, T.D., Perumalswami, P.V.
Published in Transpl Infect Dis (2015)

Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir

by Bichoupan, K., Schwartz, J. M., Martel-Laferriere, V., Giannattasio, E. R., Marfo, K., Odin, J. A., Liu, L. U., Schiano, T. D., Perumalswami, P., Bansal, M., Gaglio, P. J., Kalia, H., Dieterich, D. T., Branch, A. D., Reinus, J. F.
Published 2013

Multicenter Evaluation of the Clinical Performance and the Neutralizing Antibody Activity Prediction Properties of 10 High-Throughput Serological Assays Used in Clinical Laboratori...

by Therrien, C., Serhir, B., Bélanger-Collard, M., Skrzypczak, J., Shank, D. K., Renaud, C., Girouard, J., Loungnarath, V., Carrier, M., Brochu, G., Tourangeau, F., Gilfix, B., Piche, A., Bazin, R., Guérin, R., Lavoie, M., Martel-Laferrière, V., Fortin, C., Benoit, A., Marcoux, D., Gauthier, N., Laumaea, A. M., Gasser, R., Finzi, A., Roger, M.
Published in J Clin Microbiol (2021)